Your browser doesn't support javascript.
loading
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
Agarwal, Neeraj; Pal, Sumanta K; Hahn, Andrew W; Nussenzveig, Roberto H; Pond, Gregory R; Gupta, Sumati V; Wang, Jue; Bilen, Mehmet A; Naik, Gurudatta; Ghatalia, Pooja; Hoimes, Christopher J; Gopalakrishnan, Dharmesh; Barata, Pedro C; Drakaki, Alexandra; Faltas, Bishoy M; Kiedrowski, Lesli A; Lanman, Richard B; Nagy, Rebecca J; Vogelzang, Nicholas J; Boucher, Kenneth M; Vaishampayan, Ulka N; Sonpavde, Guru; Grivas, Petros.
Afiliação
  • Agarwal N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Hahn AW; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Nussenzveig RH; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Pond GR; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
  • Gupta SV; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Wang J; Genitourinary Oncology Section, University of Arizona Cancer Center at Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
  • Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Naik G; Department of Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Ghatalia P; Department of Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Hoimes CJ; Division of Hematology/Oncology, Case Western Reserve University, Seidman Cancer Center, Cleveland, Ohio.
  • Gopalakrishnan D; Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio.
  • Barata PC; Division of Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Drakaki A; Department of Hematology/Oncology, University of California at Los Angeles Medical Center, Los Angeles, California.
  • Faltas BM; Department of Medical Oncology, Weill-Cornell Medical College, New York City, New York.
  • Kiedrowski LA; Guardant Health Inc, Redwood, California.
  • Lanman RB; Guardant Health Inc, Redwood, California.
  • Nagy RJ; Guardant Health Inc, Redwood, California.
  • Vogelzang NJ; Department of Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada.
  • Boucher KM; Division of Biostatistics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Vaishampayan UN; Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan.
  • Sonpavde G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Grivas P; Division of Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cancer ; 124(10): 2115-2124, 2018 05 15.
Article em En | MEDLINE | ID: mdl-29517810

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células de Transição / Biomarcadores Tumorais / Neoplasias Urológicas / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células de Transição / Biomarcadores Tumorais / Neoplasias Urológicas / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article